BioSpace News Archive

Prostate cancer is the second most common cancer for men, both in the United States and worldwide.

Preventing a patient from becoming malnourished can shorten his or her hospital stay, decrease hospital fees and, most importantly, improve the patient’s quality of life.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will present two abstracts further establishing the viability of implantable neuromodulation technology to treat patients with heart failure during the European Society of Cardiology (ESC) Congress 2019 from August 31 to September 4 in Paris.

For the first time in 20 years, overdose deaths from prescription and non-prescription drugs decreased slightly in 2018, according to preliminary data from the Centers for Disease Control and Prevention.

Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will be presenting at the following investor conference and invited investors to participate by webcast.

Today, a far-reaching co-operation contract was signed between Syntellix Asia Pte. Ltd., the Singapore based Asian subsidiary and hub of highly innovative German biomedical technology pioneer Syntellix AG from Hannover and China’s leading orthopaedic implant supplier Beijing Chunlizhengda Medical Instruments Co., Ltd

Hyundai Hope On Wheels® (HHOW), a 501(c)(3) nonprofit organization, supported by Hyundai Motor America and its U.S. dealers, continues its fight against pediatric cancer and announces plans for Childhood Cancer Awareness month

Harborside Inc. (“Harborside” or the “Company”) (CSE: HBOR), today reported financial results for the three and six months ending June 30, 2019.

Fraser — the Upper Midwest’s premier provider of autism services and Minnesota’s largest early childhood provider of mental health services — recently received accreditation for its psychology internship program from the American Psychological Association Commission on Accreditation (CoA).